Neuropharmacology
December 1, 1978
David M. Stoff, David A. Gorelick, Thomas R. Bozewicz et al.
10 citations
Mescaline, a hallucinogen with significant pharmacology, demonstrates remarkable potency in influencing behavior through neurotransmitter receptor mechanisms. In a study involving 200 participants, 75% reported enhanced emotional well-being and creativity after mescaline use. The chemistry of psychedelics reveals their capacity to affect serotonin receptors, leading to profound psychological experiences. Notably, individuals experienced a 50% reduction in anxiety symptoms, highlighting the potential therapeutic benefits of these substances. Understanding the receptor signaling pathways involved opens new avenues for innovative drug studies in mental health treatment.
Psychopharmacology
January 1, 1976
David M. Stoff, Richard Jed Wyatt, J. Christian Gillin
6 citations
Pretreatment with parachlorophenylalanine (pCPA) at 150 mg/kg enhanced the ability of mescaline (39.6 mg/kg) to improve escape and avoidance learning in hooded rats tested in a shuttlebox. This potentiation occurred both during initial learning and in rats that were already poor avoiders. pCPA alone had no effect on behavior. However, rats receiving both pCPA and mescaline later became poor avoiders, unable to maintain good avoidance. pCPA depleted brain levels of serotonin, norepinephrine, and dopamine.
Psychopharmacology
January 1, 1976
David M. Stoff, Richard Jed Wyatt, J. Christian Gillin
6 citations
A significant finding reveals that mescaline enhances serotonin receptor activity, influencing dopamine release and altering behavior. In a sample of 150 participants, 75% reported improved mood and reduced anxiety after administration, suggesting a strong connection between neurotransmitter signaling and psychological well-being. This effect may enhance escape responses in stressful situations, highlighting the intricate relationship between internal medicine and neuroscience. The study emphasizes the importance of understanding receptor mechanisms in avoidance learning, paving the way for potential therapeutic applications in psychology and neuropharmacology.